ArticleInternational journal of hematology2020

A phase 1b study of blinatumomab in Japanese children with relapsed/refractory B-cell precursor acute lymphoblastic leukemia.

Keizo Horibe et al.PubMed ↗Publisher ↗

No numbers read from the abstract.